Search research articles
Contact Us
Filters
Showing results (1-10 of 43) with videos related to
Page
of 5
Sort By:
European Journal of Pharmacology
|
November 11, 1998
Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels
K A Duggan, V Z Ye
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1997
Stimulation of the gastric sodium monitor reduces hepatic angiotensin-converting enzyme activity
K A Duggan, V Z Ye
Annals of the New York Academy of Sciences
|
February 24, 2001
VIP regulates angiotensinogen synthesis in the liver
K A Duggan, V Z Ye
Clinical Science (London, England : 1979)
|
February 1, 1987
Vasoactive intestinal peptide: a direct renal natriuretic substance
K A Duggan, G J Macdonald
Clinical and Experimental Pharmacology & Physiology
|
October 24, 1998
Mechanisms underlying the decrease in circulating angiotensin II concentration after sodium loading
K A Duggan, V Z Ye
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1997
Stimulation of gastric osmoreceptors but not the sodium monitor increases renal angiotensin-converting enzyme activity
V Z Ye, K A Duggan
Annals of the New York Academy of Sciences
|
December 26, 1996
Angiotensin-converting enzyme inhibition with enalapril increases the cardiac concentration of vasoactive intestinal peptide
K A Duggan, V Z Ye
Clinical Science (London, England : 1979)
|
January 15, 2002
Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat
V Z Ye, K A Duggan
Chest
|
August 1, 1995
The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung
V Z Ye, K A Duggan
Annals of the New York Academy of Sciences
|
February 3, 1999
Effect of sodium depletion by frusemide on tissue concentrations and metabolism of VIP
K A Duggan, V Z Ye
Page
of 5
Search research articles
Search
Showing results (1-10 of 43) with videos related to
Sort By:
Page
of 5
European Journal of Pharmacology
|
November 11, 1998
Effects of enalapril on vasoactive intestinal peptide metabolism and tissue levels
K A Duggan, V Z Ye
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1997
Stimulation of the gastric sodium monitor reduces hepatic angiotensin-converting enzyme activity
K A Duggan, V Z Ye
Annals of the New York Academy of Sciences
|
February 24, 2001
VIP regulates angiotensinogen synthesis in the liver
K A Duggan, V Z Ye
Clinical Science (London, England : 1979)
|
February 1, 1987
Vasoactive intestinal peptide: a direct renal natriuretic substance
K A Duggan, G J Macdonald
Clinical and Experimental Pharmacology & Physiology
|
October 24, 1998
Mechanisms underlying the decrease in circulating angiotensin II concentration after sodium loading
K A Duggan, V Z Ye
Clinical and Experimental Pharmacology & Physiology
|
June 1, 1997
Stimulation of gastric osmoreceptors but not the sodium monitor increases renal angiotensin-converting enzyme activity
V Z Ye, K A Duggan
Annals of the New York Academy of Sciences
|
December 26, 1996
Angiotensin-converting enzyme inhibition with enalapril increases the cardiac concentration of vasoactive intestinal peptide
K A Duggan, V Z Ye
Clinical Science (London, England : 1979)
|
January 15, 2002
Vasoactive intestinal peptide down-regulates the intrahepatic renin-angiotensin system in the anaesthetized rat
V Z Ye, K A Duggan
Chest
|
August 1, 1995
The effect of dietary sodium on the concentrations of vasoactive intestinal peptide in plasma and lung
V Z Ye, K A Duggan
Annals of the New York Academy of Sciences
|
February 3, 1999
Effect of sodium depletion by frusemide on tissue concentrations and metabolism of VIP
K A Duggan, V Z Ye
Page
of 5